Seroatlas · Human Serome Atlas

SIRPA

Tyrosine-protein phosphatase non-receptor type substrate 1

Also known as: BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SHPS1_HUMAN, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P78324
Gene
SIRPA
Ensembl
ENSG00000198053
Chromosome
20
Canonical length
504 aa
Protein class
CD markers, Plasma proteins, Predicted membrane proteins

OverviewNCBI Gene

The protein encoded by this gene is a member of the signal-regulatory-protein (SIRP) family, and also belongs to the immunoglobulin superfamily. SIRP family members are receptor-type transmembrane glycoproteins known to be involved in the negative regulation of receptor tyrosine kinase-coupled signaling processes. This protein can be phosphorylated by tyrosine kinases. The phospho-tyrosine residues of this PTP have been shown to recruit SH2 domain containing tyrosine phosphatases (PTP), and serve as substrates of PTPs. This protein was found to participate in signal transduction mediated by various growth factor receptors. CD47 has been demonstrated to be a ligand for this receptor protein. This gene and its product share very high similarity with several other members of the SIRP family. These related genes are located in close proximity to each other on chromosome 20p13. Multiple alternatively spliced transcript variants have been determined for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

504 residues, UniProt reviewed canonical sequence.

>P78324|SIRPA
     1  MEPAGPAPGR LGPLLCLLLA ASCAWSGVAG EEELQVIQPD KSVLVAAGET ATLRCTATSL
    61  IPVGPIQWFR GAGPGRELIY NQKEGHFPRV TTVSDLTKRN NMDFSIRIGN ITPADAGTYY
   121  CVKFRKGSPD DVEFKSGAGT ELSVRAKPSA PVVSGPAARA TPQHTVSFTC ESHGFSPRDI
   181  TLKWFKNGNE LSDFQTNVDP VGESVSYSIH STAKVVLTRE DVHSQVICEV AHVTLQGDPL
   241  RGTANLSETI RVPPTLEVTQ QPVRAENQVN VTCQVRKFYP QRLQLTWLEN GNVSRTETAS
   301  TVTENKDGTY NWMSWLLVNV SAHRDDVKLT CQVEHDGQPA VSKSHDLKVS AHPKEQGSNT
   361  AAENTGSNER NIYIVVGVVC TLLVALLMAA LYLVRIRQKK AQGSTSSTRL HEPEKNAREI
   421  TQDTNDITYA DLNLPKGKKP APQAAEPNNH TEYASIQTSP QPASEDTLTY ADLDMVHLNR
   481  TPKQPAPKPE PSFSEYASVQ VPRK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SIRPA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.45
Highest tissue expression
160 nTPM

Expression across tissuesHPA

Tissue

  • cerebral cortex: 160 nTPM
  • cerebellum: 112 nTPM
  • amygdala: 102 nTPM
  • basal ganglia: 93 nTPM
  • hippocampal formation: 83 nTPM
  • midbrain: 52 nTPM

Single-cell type

  • neutrophils: 801 nCPM
  • monocytes: 215 nCPM
  • neutrophil progenitors: 183 nCPM
  • astrocytes: 160 nCPM
  • hofbauer cells: 143 nCPM
  • macrophages: 128 nCPM

Immune cell

  • neutrophil: 51 nTPM
  • eosinophil: 49 nTPM
  • classical monocyte: 24 nTPM
  • myeloid DC: 14 nTPM
  • total PBMC: 9.9 nTPM
  • intermediate monocyte: 6 nTPM

Brain region

  • cerebral cortex: 245 nTPM
  • amygdala: 227 nTPM
  • basal ganglia: 222 nTPM
  • thalamus: 206 nTPM
  • hippocampal formation: 198 nTPM
  • midbrain: 188 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.43
gnomAD pLI
0.67
gnomAD missense Z
1.06
DepMap mean gene effect
0.08
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SIRPA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SIRPA as an antibody target. Whether an autoantibody or antibody against SIRPA could matter depends on whether native SIRPA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SIRPA is annotated at the cell surface, where native SIRPA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label SIRPA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SIRPA. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...